Received Feb 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | — | — |
57 year old patient received Bexsero; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a 57-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. The patient's past medical history included neoplasm (part of her pancreas was removed due to a tumor) and splenectomy. In OCT-2024, the patient received the 1st dose of Bexsero. In OCT-2024, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: 57 year old patient received Bexsero). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 16-JAN-2025 Patient reported that she received first shot of Bexsero in early October 2024, her physician has ordered this vaccine for her due to her pre-existing medical condition. Patient received Bexsero at the age of 57 years which led to inappropriate age at vaccine administration.
Medical History/Concurrent Conditions: Neoplasm (part of her pancreas was removed due to a tumor); Splenectomy